Retraction Notice to: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment

Main text

(Molecular Therapy: Oncolytics 24, 371–384; March 2022)

Molecular Therapy – Oncolytics is retracting this article at the request of the editors.

After the article was published, the authors requested to remove an author who did not agree to be listed (in violation of the journal’s policy that all authors approve the manuscript). The authors also requested to change the cell line used in the study, BT549, to MDA231; this change would alter the paper entirely.

While these issues were being investigated, the editors discovered that some of the data and text in this article were also submitted to Frontiers in Immunology: Cancer Immunity and Immunotherapy in July 2021 and were published in the article “Naringenin Regulates FKBP4/NR3C1/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell” (Xiong et al., 2022, Front. Immunol. 12, https://dx.doi.org/10.3389/fimmu.2021.745111) in January 2022, aligning with the submission and publication dates of the authors’ article in Molecular Therapy – Oncolytics, which is in violation of the journal’s dual publication policy. These issues constitute a severe abuse of the scientific publishing system. The corresponding author agrees with the retraction of this article, though he maintains that these issues do not affect the conclusions.